Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: HIF-1 signaling pathway (mmu04066)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
AK045366
KLA  ATP  ATP+KLA
 AK045366 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230107A03 product:unclassifiable, full insert sequence [AK045366] KLA .88 .80 .79 .86 .89 .97 1.07
ATP 1.21 1.67 2.40 3.50 2.58 1.29 1.12
KLA/ATP .97 .98 1.30 1.76 1.26 1.15 1.06
AK169742
KLA  ATP  ATP+KLA
 AK169742 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430016M08 product:glyceraldehyde-3-phosphate dehydrogenase, full insert sequence. [AK169742] KLA .82 .94 .91 .90 1.13 .93 1.79
ATP .59 .66 .72 .89 1.88 1.96 1.26
KLA/ATP .75 .69 .70 .84 1.00 1.13 1.46
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Aldoa
KLA  ATP  ATP+KLA
 NM_007438 aldolase 1, A isoform (Aldoa), mRNA [NM_007438] KLA .81 .83 .75 .81 .83 .80 1.22
ATP .97 .93 .78 .78 1.01 1.14 1.35
KLA/ATP .80 .86 .84 .70 .80 .81 1.12
Angpt1
KLA  ATP  ATP+KLA
 NM_009640 angiopoietin 1 (Angpt1), mRNA [NM_009640] KLA 1.19 1.24 1.37 1.49 1.45 1.20 .99
ATP 1.02 1.05 1.03 1.05 1.04 1.01 1.06
KLA/ATP 1.21 1.23 1.33 1.36 1.30 1.21 1.07
Angpt2
KLA  ATP  ATP+KLA
 NM_007426 angiopoietin 2 (Angpt2), mRNA [NM_007426] KLA .22 .22 .18 .22 .31 1.11 2.43
ATP .93 .92 1.36 3.33 5.55 1.44 7.53
KLA/ATP .20 .20 .28 .54 1.94 2.41 6.55
Angpt4
KLA  ATP  ATP+KLA
 NM_009641 angiopoietin 4 (Angpt4), mRNA [NM_009641] KLA 1.01 .99 1.00 1.09 .96 .96 .88
ATP .98 .97 1.02 .95 1.02 1.01 .93
KLA/ATP .97 1.01 1.02 .96 .97 .93 .99
Arnt
KLA  ATP  ATP+KLA
 AK037762 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130047M16 product:aryl hydrocarbon receptor nuclear translocator, full insert sequence. [AK037762] KLA 1.01 .87 .97 .92 1.13 .91 1.00
ATP 1.16 1.22 1.22 .84 1.57 1.19 1.05
KLA/ATP 1.06 1.06 1.08 .95 1.40 1.18 1.06
Arnt
KLA  ATP  ATP+KLA
 NM_001037737 aryl hydrocarbon receptor nuclear translocator (Arnt), transcript variant 1, mRNA [NM_001037737] KLA 1.23 1.27 1.32 1.23 1.34 1.33 1.30
ATP 1.02 1.09 .96 .90 .99 1.33 1.38
KLA/ATP 1.30 1.28 1.05 1.12 1.07 1.64 1.89
Arnt
KLA  ATP  ATP+KLA
 U14333 aromatic hydrocarbon receptor nuclear translocator Arnt (ARNT) mRNA, complete cds. [U14333] KLA 1.78 1.78 1.78 1.85 1.64 1.71 1.40
ATP .96 1.05 1.37 1.24 1.19 2.13 2.37
KLA/ATP 1.72 1.87 1.87 1.83 1.53 2.53 3.65
Bcl2
KLA  ATP  ATP+KLA
 NM_009741 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 1, mRNA [NM_009741] KLA .30 .26 .25 .25 .34 .38 .26
ATP .97 .89 1.50 1.04 .99 .29 .52
KLA/ATP .28 .26 .40 .33 .62 .29 .12
Bcl2
KLA  ATP  ATP+KLA
 NM_177410 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 2, mRNA [NM_177410] KLA .33 .33 .37 .42 .49 .46 .39
ATP 1.07 1.12 1.22 1.56 1.00 .38 .76
KLA/ATP .35 .34 .54 .89 .76 .36 .23
Camk2a
KLA  ATP  ATP+KLA
 NM_177407 calcium/calmodulin-dependent protein kinase II alpha (Camk2a), transcript variant 2, mRNA [NM_177407] KLA .98 .97 .98 .95 .97 1.02 .97
ATP .98 1.11 1.02 .89 .94 .89 .82
KLA/ATP .99 .95 1.02 .88 .88 .87 .87
Camk2b
KLA  ATP  ATP+KLA
 NM_007595 calcium/calmodulin-dependent protein kinase II, beta (Camk2b), mRNA [NM_007595] KLA 1.09 1.28 1.42 1.41 1.37 1.24 .68
ATP .94 .87 .95 .91 .67 .44 .48
KLA/ATP 1.16 1.24 1.40 1.13 1.14 .81 .49
Camk2d
KLA  ATP  ATP+KLA
 AK032524 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430579P05 product:calcium/calmodulin-dependent protein kinase II, delta, full insert sequence. [AK032524] KLA 1.31 1.45 1.42 1.21 1.34 1.18 1.16
ATP 1.04 1.29 1.39 1.24 .94 .91 1.22
KLA/ATP 1.46 1.64 1.42 1.24 1.00 .93 1.10
Camk2d
KLA  ATP  ATP+KLA
 NM_001025439 calcium/calmodulin-dependent protein kinase II, delta (Camk2d), transcript variant 1, mRNA [NM_001025439] KLA 1.76 1.75 1.72 1.89 1.47 1.55 1.24
ATP 1.06 1.06 .93 1.01 1.22 .98 2.28
KLA/ATP 1.84 1.78 1.40 1.57 1.07 .60 1.97
Camk2g
KLA  ATP  ATP+KLA
 NM_178597 calcium/calmodulin-dependent protein kinase II gamma (Camk2g), transcript variant 1, mRNA [NM_178597] KLA .23 .24 .23 .44 .70 .73 .70
ATP .91 .85 1.07 .86 .58 .59 .95
KLA/ATP .22 .20 .35 .25 .54 .59 .71
Cdkn1a
KLA  ATP  ATP+KLA
 NM_007669 cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a), transcript variant 1, mRNA [NM_007669] KLA 4.72 4.90 4.96 3.73 2.11 1.14 1.02
ATP 1.14 1.52 .95 1.69 1.47 2.21 .50
KLA/ATP 5.99 7.08 3.86 6.37 3.00 2.55 2.05
Cdkn1b
KLA  ATP  ATP+KLA
 NM_009875 cyclin-dependent kinase inhibitor 1B (Cdkn1b), mRNA [NM_009875] KLA .81 .84 .84 .91 .93 .88 .97
ATP .99 1.09 .97 1.06 1.48 .94 .91
KLA/ATP .83 .91 1.04 1.36 1.48 1.06 1.09
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Cul2
KLA  ATP  ATP+KLA
 NM_029402 cullin 2 (Cul2), mRNA [NM_029402] KLA 2.33 2.37 2.43 1.90 1.34 1.10 1.09
ATP .98 .92 .98 .78 .73 .90 .76
KLA/ATP 2.27 2.19 1.86 1.53 1.07 .95 .81
Cybb
KLA  ATP  ATP+KLA
 NM_007807 cytochrome b-245, beta polypeptide (Cybb), mRNA [NM_007807] KLA 5.43 5.43 5.59 5.19 5.71 5.00 5.08
ATP 1.08 1.18 1.19 1.64 1.68 2.73 1.82
KLA/ATP 5.34 5.62 4.98 6.75 3.74 3.36 3.96
Edn1
KLA  ATP  ATP+KLA
 NM_010104 endothelin 1 (Edn1), mRNA [NM_010104] KLA 73.36 71.33 61.92 68.69 46.94 32.60 13.54
ATP 1.23 1.89 4.18 10.86 17.85 11.03 1.91
KLA/ATP 67.27 76.78 116.70 90.29 76.38 29.71 8.04
Egf
KLA  ATP  ATP+KLA
 NM_010113 epidermal growth factor (Egf), mRNA [NM_010113] KLA .89 .90 .81 .83 .83 .86 .92
ATP 1.03 1.03 .95 .84 .67 .79 .88
KLA/ATP .86 .86 .77 .77 .69 .78 .83
Egfr
KLA  ATP  ATP+KLA
 NM_007912 epidermal growth factor receptor (Egfr), transcript variant 2, mRNA [NM_007912] KLA 1.10 1.07 1.14 1.11 1.08 1.03 .90
ATP .99 1.00 1.04 .98 .97 1.15 1.14
KLA/ATP 1.07 1.10 1.16 1.08 1.01 .97 .94
Egfr
KLA  ATP  ATP+KLA
 NM_207655 epidermal growth factor receptor (Egfr), transcript variant 1, mRNA [NM_207655] KLA 1.57 1.44 1.47 1.31 .96 .92 .76
ATP .97 .93 1.10 1.00 1.41 2.97 .86
KLA/ATP 1.44 1.50 1.61 1.30 1.14 1.21 .82
Egln1
KLA  ATP  ATP+KLA
 NM_053207 EGL nine homolog 1 (C. elegans) (Egln1), mRNA [NM_053207] KLA .60 .60 .62 .54 .46 .48 .73
ATP 1.04 1.10 .94 1.00 .78 .84 .65
KLA/ATP .65 .64 .56 .53 .49 .47 .41
Egln2
KLA  ATP  ATP+KLA
 NM_053208 EGL nine homolog 2 (C. elegans) (Egln2), mRNA [NM_053208] KLA 1.12 1.22 1.40 1.55 1.86 1.39 1.19
ATP .94 .82 .61 .52 .74 1.26 1.29
KLA/ATP 1.11 1.04 .87 .73 1.28 1.53 1.54
Egln3
KLA  ATP  ATP+KLA
 NM_028133 EGL nine homolog 3 (C. elegans) (Egln3), mRNA [NM_028133] KLA .90 .90 .76 .73 .69 .83 1.38
ATP .96 1.03 .88 1.21 1.49 2.94 .90
KLA/ATP .88 .96 .78 .90 .98 1.18 1.15
Eif4e
KLA  ATP  ATP+KLA
 NM_007917 eukaryotic translation initiation factor 4E (Eif4e), mRNA [NM_007917] KLA 1.22 1.06 .94 .97 .83 .85 1.18
ATP 1.00 1.01 1.27 1.27 2.61 2.08 .97
KLA/ATP .95 1.04 1.37 1.16 1.50 1.28 .73
Eif4e2
KLA  ATP  ATP+KLA
 NM_001039169 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 2, mRNA [NM_001039169] KLA 1.53 1.51 1.54 1.52 1.55 1.49 1.55
ATP 1.02 1.08 1.12 1.45 1.61 1.51 1.15
KLA/ATP 1.56 1.60 1.59 1.90 1.90 1.75 1.68
Eif4e2
KLA  ATP  ATP+KLA
 NM_023314 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 3, mRNA [NM_023314] KLA 1.42 1.40 1.43 1.35 1.58 1.65 1.42
ATP 1.06 1.06 1.04 .98 1.41 2.07 2.04
KLA/ATP 1.46 1.48 1.40 1.45 1.64 2.12 2.30
Eif4ebp1
KLA  ATP  ATP+KLA
 NM_007918 eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1), mRNA [NM_007918] KLA .66 .64 .59 .67 .81 .97 .97
ATP .97 .94 1.10 1.05 1.99 1.60 .91
KLA/ATP .62 .61 .68 .68 1.50 1.24 .95
Eno1
KLA  ATP  ATP+KLA
 NM_023119 enolase 1, alpha non-neuron (Eno1), mRNA [NM_023119] KLA .95 1.06 1.16 .78 1.04 .91 1.33
ATP 1.32 1.63 .81 1.78 1.08 1.07 1.65
KLA/ATP 1.50 1.43 .46 1.67 .61 1.02 1.97
Eno2
KLA  ATP  ATP+KLA
 NM_013509 enolase 2, gamma neuronal (Eno2), mRNA [NM_013509] KLA .84 .85 .72 .81 1.23 1.24 2.08
ATP 1.07 1.13 1.14 3.24 4.11 1.61 2.43
KLA/ATP .93 .89 .85 1.68 3.37 1.66 2.69
Eno3
KLA  ATP  ATP+KLA
 NM_007933 enolase 3, beta muscle (Eno3), mRNA [NM_007933] KLA .85 .86 .88 .84 .67 .70 1.00
ATP .92 .90 1.28 1.20 .96 .59 .68
KLA/ATP .82 .90 1.10 .99 .94 .52 .51
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Epo
KLA  ATP  ATP+KLA
 NM_007942 erythropoietin (Epo), mRNA [NM_007942] KLA 1.00 1.05 1.08 1.01 1.03 1.08 1.04
ATP .95 .97 .97 1.04 1.02 .99 1.01
KLA/ATP 1.03 1.01 .97 1.00 1.00 1.10 1.00
Erbb2
KLA  ATP  ATP+KLA
 NM_001003817 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (Erbb2), mRNA [NM_001003817] KLA 1.01 1.00 .98 1.01 .98 .99 .97
ATP .99 1.00 1.00 1.00 .96 .98 .99
KLA/ATP 1.00 1.01 1.01 1.02 .96 .98 .97
Flt1
KLA  ATP  ATP+KLA
 NM_010228 FMS-like tyrosine kinase 1 (Flt1), mRNA [NM_010228] KLA 3.02 2.74 2.92 3.54 3.71 3.82 1.43
ATP .88 .85 1.07 .85 .94 1.31 1.16
KLA/ATP 2.60 2.99 3.08 2.13 2.23 2.00 2.59
Frap1
KLA  ATP  ATP+KLA
 NM_020009 FK506 binding protein 12-rapamycin associated protein 1 (Frap1), mRNA [NM_020009] KLA 1.37 1.32 1.46 1.57 1.83 1.29 1.28
ATP 1.12 1.07 .95 .91 .80 .77 1.03
KLA/ATP 1.45 1.51 1.50 1.11 .89 .87 1.01
Gapdh
KLA  ATP  ATP+KLA
 NM_008084 glyceraldehyde-3-phosphate dehydrogenase (Gapdh), mRNA [NM_008084] KLA .83 .87 .98 .70 .98 .82 1.34
ATP 1.24 1.33 .70 1.26 .95 .96 1.64
KLA/ATP 1.08 1.18 .50 .98 .61 .79 1.40
Hif1a
KLA  ATP  ATP+KLA
 NM_010431 hypoxia inducible factor 1, alpha subunit (Hif1a), mRNA [NM_010431] KLA 2.52 2.50 2.52 1.78 1.87 1.39 1.96
ATP 1.16 1.37 1.11 1.44 2.11 4.46 1.97
KLA/ATP 2.76 2.92 1.75 2.60 2.39 4.75 5.37
Hk1
KLA  ATP  ATP+KLA
 J05277 gb|Mouse hexokinase mRNA, complete cds [J05277] KLA 1.49 1.45 1.66 1.78 1.51 1.29 .99
ATP 1.11 1.05 1.15 1.20 2.31 2.17 1.09
KLA/ATP 1.63 1.51 1.70 1.47 1.94 1.92 1.40
Hk1
KLA  ATP  ATP+KLA
 NM_010438 hexokinase 1 (Hk1), nuclear gene encoding mitochondrial protein, mRNA [NM_010438] KLA 1.58 1.75 2.05 1.84 1.96 1.67 1.31
ATP 1.06 1.25 1.01 1.49 2.23 1.79 1.20
KLA/ATP 1.87 1.96 1.51 1.93 1.71 1.94 1.72
Hk2
KLA  ATP  ATP+KLA
 NM_013820 hexokinase 2 (Hk2), mRNA [NM_013820] KLA 4.09 4.09 3.17 2.37 1.53 1.62 2.02
ATP .98 .92 1.08 2.24 3.82 3.86 .97
KLA/ATP 4.07 3.94 4.17 3.53 5.42 4.65 1.54
Hk3
KLA  ATP  ATP+KLA
 NM_001033245 hexokinase 3 (Hk3), nuclear gene encoding mitochondrial protein, mRNA [NM_001033245] KLA 1.52 1.68 1.94 1.85 2.21 2.89 1.98
ATP 1.01 1.07 .87 .99 1.01 1.26 2.62
KLA/ATP 1.63 1.74 1.67 1.69 1.44 2.01 3.53
Hkdc1
KLA  ATP  ATP+KLA
 NM_145419 hexokinase domain containing 1 (Hkdc1), mRNA [NM_145419] KLA 1.10 1.08 1.12 1.12 1.02 1.07 1.04
ATP .96 1.04 1.06 4.28 10.50 3.91 1.34
KLA/ATP .98 1.04 1.14 5.33 12.44 8.68 1.77
Hmox1
KLA  ATP  ATP+KLA
 NM_010442 heme oxygenase (decycling) 1 (Hmox1), mRNA [NM_010442] KLA .30 .31 .32 .45 1.00 2.36 3.22
ATP .91 .98 .96 1.24 2.53 5.47 2.27
KLA/ATP .31 .30 .40 .87 2.26 4.40 3.94
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Igf1
KLA  ATP  ATP+KLA
 AK050118 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730016P09 product:unclassifiable, full insert sequence. [AK050118] KLA .13 .14 .15 .16 .22 .34 .48
ATP 1.78 2.05 1.37 .72 .34 .41 .58
KLA/ATP .24 .45 .50 .24 .20 .26 .68
Igf1
KLA  ATP  ATP+KLA
 NM_010512 insulin-like growth factor 1 (Igf1), transcript variant 1, mRNA [NM_010512] KLA .84 .78 .76 .67 .54 .48 .59
ATP .97 .98 1.13 1.13 1.03 .88 .89
KLA/ATP .82 .81 .93 .86 .83 .65 .89
Igf1
KLA  ATP  ATP+KLA
 NM_184052 insulin-like growth factor 1 (Igf1), transcript variant 2, mRNA [NM_184052] KLA .77 .82 .76 .65 .60 .52 .69
ATP 1.01 1.07 .98 1.06 1.03 .78 .94
KLA/ATP .89 .86 .77 .80 .75 .65 .89
Igf1r
KLA  ATP  ATP+KLA
 NM_010513 insulin-like growth factor I receptor (Igf1r), mRNA [NM_010513] KLA 1.32 1.32 1.08 .91 .55 .48 .45
ATP 1.03 1.06 1.06 1.29 1.31 1.45 .47
KLA/ATP 1.30 1.37 1.11 1.00 .93 1.02 .45
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Il6ra
KLA  ATP  ATP+KLA
 NM_010559 interleukin 6 receptor, alpha (Il6ra), mRNA [NM_010559] KLA .50 .53 .65 .86 1.36 1.72 1.00
ATP .97 1.20 1.17 1.25 .74 .67 .95
KLA/ATP .50 .60 .61 .64 .59 .76 1.14
Ins1
KLA  ATP  ATP+KLA
 NM_008386 insulin I (Ins1), mRNA [NM_008386] KLA 1.00 .99 .99 1.03 1.01 .98 1.06
ATP .97 1.03 1.00 1.03 .99 1.07 1.05
KLA/ATP 1.03 .93 .98 1.04 1.07 1.03 1.01
Ins2
KLA  ATP  ATP+KLA
 NM_008387 insulin II (Ins2), mRNA [NM_008387] KLA .99 1.00 1.00 1.01 1.00 1.02 1.00
ATP 1.01 .99 1.00 1.00 .98 .99 1.01
KLA/ATP .99 1.01 1.00 .98 .99 .99 .98
Insr
KLA  ATP  ATP+KLA
 NM_010568 insulin receptor (Insr), mRNA [NM_010568] KLA .75 .81 .77 .69 .69 .69 .83
ATP 1.07 1.06 .88 .79 .73 .77 .83
KLA/ATP .80 .80 .72 .71 .64 .64 .70
Ldha
KLA  ATP  ATP+KLA
 NM_010699 lactate dehydrogenase A (Ldha), mRNA [NM_010699] KLA .89 .80 .84 .93 .96 1.04 1.23
ATP 1.05 1.04 .96 .87 1.21 1.43 1.11
KLA/ATP .93 .87 .87 .93 1.24 1.53 .96
Ltbr
KLA  ATP  ATP+KLA
 NM_010736 lymphotoxin B receptor (Ltbr), mRNA [NM_010736] KLA .78 .77 .80 .95 1.08 1.39 1.36
ATP .94 .86 1.00 .83 .74 1.18 1.37
KLA/ATP .69 .71 .74 .68 .85 1.04 1.69
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Map2k2
KLA  ATP  ATP+KLA
 NM_023138 mitogen-activated protein kinase kinase 2 (Map2k2), mRNA [NM_023138] KLA .96 1.01 1.09 .99 1.11 1.15 1.42
ATP 1.07 1.05 .74 .86 1.04 1.16 1.21
KLA/ATP 1.14 1.03 .68 .78 .85 1.01 1.20
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mknk1
KLA  ATP  ATP+KLA
 NM_021461 MAP kinase-interacting serine/threonine kinase 1 (Mknk1), mRNA [NM_021461] KLA .78 .81 .88 .86 .98 1.12 .93
ATP 1.04 1.03 1.03 1.07 .70 .67 1.09
KLA/ATP .83 .83 .81 .84 .66 .88 1.12
Mknk2
KLA  ATP  ATP+KLA
 NM_021462 MAP kinase-interacting serine/threonine kinase 2 (Mknk2), mRNA [NM_021462] KLA .19 .18 .16 .15 .20 .50 .62
ATP .89 .86 1.35 2.05 1.76 1.52 1.29
KLA/ATP .19 .17 .32 .99 1.61 2.33 1.97
Mm.13153
0
KLA  ATP  ATP+KLA
 161086915 Unknown KLA 1.00 1.07 1.14 1.08 .97 1.00 .93
ATP 1.04 .99 1.00 .95 .99 1.02 .90
KLA/ATP 1.08 1.18 1.14 1.16 1.04 1.06 1.08
Mm.19961
KLA  ATP  ATP+KLA
 142378163 Unknown KLA 1.19 1.17 1.10 1.11 1.10 1.16 1.10
ATP .99 1.04 1.13 1.13 1.02 1.06 1.00
KLA/ATP 1.27 1.24 1.25 1.24 1.19 1.08 1.09
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.27574
2
KLA  ATP  ATP+KLA
 112983655 Unknown KLA 1.35 1.16 .94 .85 .45 .33 .31
ATP .90 .86 1.17 1.09 1.18 1.21 .38
KLA/ATP 1.12 1.22 1.19 .91 .90 .83 .33
Mm.28924
8
KLA  ATP  ATP+KLA
 148747277 Unknown KLA 1.36 1.32 1.33 1.38 1.29 1.32 .98
ATP .86 .92 1.42 1.26 1.10 .95 .57
KLA/ATP 1.16 1.34 1.72 1.53 1.42 .87 .61
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Mm.44463
KLA  ATP  ATP+KLA
 118129851 Unknown KLA 1.01 .98 .97 1.02 .93 1.06 1.05
ATP .97 1.01 1.04 1.06 1.02 1.08 .97
KLA/ATP 1.02 1.06 .95 1.04 1.09 1.14 1.03
Mm.47351
0
KLA  ATP  ATP+KLA
 162287332 Unknown KLA 4.46 4.82 5.29 4.00 2.26 1.25 1.10
ATP 1.24 1.72 1.02 2.08 1.66 2.53 .55
KLA/ATP 6.11 7.67 4.29 6.99 3.11 2.86 2.30
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nos2
KLA  ATP  ATP+KLA
 NM_010927 nitric oxide synthase 2, inducible, macrophage (Nos2), mRNA [NM_010927] KLA 13.50 16.36 25.65 23.25 24.78 15.99 6.48
ATP 1.03 1.03 1.48 1.66 1.65 5.55 1.70
KLA/ATP 16.01 17.41 19.06 25.50 20.84 29.92 29.80
Nos3
KLA  ATP  ATP+KLA
 NM_008713 nitric oxide synthase 3, endothelial cell (Nos3), mRNA [NM_008713] KLA .83 .79 .76 .78 .77 .85 .96
ATP 1.03 1.09 1.03 1.02 .85 .96 1.84
KLA/ATP .80 .78 .79 .80 .79 .78 .91
Nox1
KLA  ATP  ATP+KLA
 NM_172203 NADPH oxidase 1 (Nox1), mRNA [NM_172203] KLA 2.18 2.93 3.44 2.51 2.84 1.77 1.10
ATP 1.01 .99 1.13 1.21 1.09 1.00 1.03
KLA/ATP 3.07 3.07 1.88 2.30 1.55 1.60 1.14
Nox3
KLA  ATP  ATP+KLA
 NM_198958 NADPH oxidase 3 (Nox3), mRNA [NM_198958] KLA .98 .99 1.01 1.00 1.01 1.07 1.04
ATP 1.04 .95 .95 .96 1.02 .97 .92
KLA/ATP .99 1.03 .93 .99 .93 .95 .99
Nppa
KLA  ATP  ATP+KLA
 NM_008725 natriuretic peptide precursor type A (Nppa), mRNA [NM_008725] KLA 1.12 1.09 1.12 1.12 1.09 1.10 1.14
ATP 1.00 1.01 1.06 1.05 1.05 1.09 1.12
KLA/ATP 1.16 1.17 1.18 1.11 1.12 1.06 1.11
Pdha1
KLA  ATP  ATP+KLA
 NM_008810 pyruvate dehydrogenase E1 alpha 1 (Pdha1), nuclear gene encoding mitochondrial protein, mRNA [NM_008810] KLA .92 .96 .94 .92 .94 1.04 1.18
ATP .98 1.03 1.14 1.10 1.02 1.05 .91
KLA/ATP .93 .93 .97 .94 .81 .82 .69
Pdha2
KLA  ATP  ATP+KLA
 NM_008811 pyruvate dehydrogenase E1 alpha 2 (Pdha2), mRNA [NM_008811] KLA 1.04 .95 .98 .99 1.00 1.04 .98
ATP 1.00 .97 .95 1.00 1.01 .99 1.01
KLA/ATP 1.05 1.07 .91 1.02 .98 1.00 1.05
Pdhb
KLA  ATP  ATP+KLA
 NM_024221 pyruvate dehydrogenase (lipoamide) beta (Pdhb), mRNA [NM_024221] KLA 1.14 1.05 1.00 .97 1.03 .90 .88
ATP 1.08 1.10 1.12 1.23 1.24 1.24 1.21
KLA/ATP 1.01 1.16 1.13 1.21 1.23 1.44 1.26
Pdk1
KLA  ATP  ATP+KLA
 AK165090 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330005M21 product:hypothetical protein, full insert sequence. [AK165090] KLA .86 .77 .71 .67 .45 .29 .35
ATP 1.06 .88 1.21 .72 .60 .26 .15
KLA/ATP .81 .74 .97 .57 .51 .22 .09
Pdk1
KLA  ATP  ATP+KLA
 NM_172665 pyruvate dehydrogenase kinase, isoenzyme 1 (Pdk1), nuclear gene encoding mitochondrial protein, mRNA [NM_172665] KLA .92 .94 .91 .79 .63 .46 .51
ATP .95 1.03 1.06 1.02 .63 .31 .37
KLA/ATP .88 .91 .91 .89 .62 .31 .27
Pfkfb1
KLA  ATP  ATP+KLA
 NM_008824 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 (Pfkfb1), mRNA [NM_008824] KLA .98 .94 .94 1.08 .86 .91 .96
ATP .94 .86 .86 .57 .49 .77 .56
KLA/ATP .96 .90 .87 .58 .62 .68 .63
Pfkfb2
KLA  ATP  ATP+KLA
 BC018418 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2, mRNA (cDNA clone MGC:25723 IMAGE:3979400), complete cds. [BC018418] KLA .88 1.00 .92 .91 1.00 .99 1.01
ATP 1.13 1.04 .99 .92 .94 .95 1.37
KLA/ATP .86 .87 .88 .84 .90 .89 1.05
Pfkfb2
KLA  ATP  ATP+KLA
 NM_008825 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (Pfkfb2), mRNA [NM_008825] KLA .65 .68 .68 .67 .70 .79 .84
ATP .97 .99 1.01 .87 .68 .70 1.16
KLA/ATP .67 .69 .70 .67 .69 .65 .78
Pfkfb3
KLA  ATP  ATP+KLA
 NM_133232 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (Pfkfb3), mRNA [NM_133232] KLA 7.38 8.57 9.97 10.42 11.55 7.07 6.18
ATP .99 1.07 1.47 3.74 5.65 9.34 2.84
KLA/ATP 7.53 8.77 9.99 13.46 15.00 19.74 21.11
Pfkfb4
KLA  ATP  ATP+KLA
 NM_173019 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (Pfkfb4), mRNA [NM_173019] KLA .27 .28 .28 .31 .58 .84 .74
ATP 1.00 .79 .91 .44 .57 1.19 1.01
KLA/ATP .29 .25 .30 .19 .31 .65 .88
Pfkl
KLA  ATP  ATP+KLA
 NM_008826 phosphofructokinase, liver, B-type (Pfkl), mRNA [NM_008826] KLA 1.19 1.33 1.34 1.23 1.57 1.49 2.02
ATP 1.17 1.34 1.04 1.45 .92 1.53 .97
KLA/ATP 1.54 1.64 1.36 1.91 1.17 .89 1.61
Pgk1
KLA  ATP  ATP+KLA
 NM_008828 phosphoglycerate kinase 1 (Pgk1), mRNA [NM_008828] KLA .98 1.04 1.04 .99 1.01 1.03 1.16
ATP 1.00 .94 .70 .64 .79 1.34 1.54
KLA/ATP 1.02 .96 .80 .72 .70 .90 1.24
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Plcg2
KLA  ATP  ATP+KLA
 NM_172285 phospholipase C, gamma 2 (Plcg2), mRNA [NM_172285] KLA .76 .74 .68 .66 .71 .92 .95
ATP .96 .90 .95 .87 .81 .79 .91
KLA/ATP .76 .71 .69 .62 .72 .78 .68
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Rbx1
KLA  ATP  ATP+KLA
 NM_019712 ring-box 1 (Rbx1), mRNA [NM_019712] KLA 1.04 1.01 .98 1.09 1.06 1.14 1.09
ATP .92 .89 1.13 1.16 1.68 1.07 .83
KLA/ATP .99 .99 1.25 1.31 2.63 2.06 .67
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rps6
KLA  ATP  ATP+KLA
 AK013825 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900086I01 product:ribosomal protein S6, full insert sequence. [AK013825] KLA 1.04 1.06 1.03 .99 .94 .96 1.26
ATP 1.01 1.00 1.04 .99 .99 .94 1.12
KLA/ATP 1.02 1.08 .95 1.04 .94 .97 .90
Rps6
KLA  ATP  ATP+KLA
 NM_009096 ribosomal protein S6 (Rps6), mRNA [NM_009096] KLA 1.01 1.01 .94 .87 .89 .66 .72
ATP 1.11 1.07 1.10 1.12 1.12 1.03 .47
KLA/ATP .96 1.04 1.22 1.10 .86 .84 .40
Rps6kb1
KLA  ATP  ATP+KLA
 NM_001114334 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 1, mRNA [NM_001114334] KLA .99 1.00 .90 .89 .99 .99 .92
ATP 1.01 .96 1.00 .79 1.36 1.19 .72
KLA/ATP 1.08 .99 .93 .92 1.18 .90 .56
Rps6kb1
KLA  ATP  ATP+KLA
 NM_028259 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 2, mRNA [NM_028259] KLA 1.01 .93 1.07 1.04 .99 .99 .98
ATP 1.09 1.05 1.00 1.01 1.08 1.03 1.03
KLA/ATP 1.07 1.04 .94 .98 1.03 1.05 1.05
Rps6kb2
KLA  ATP  ATP+KLA
 AK090093 kidney CCL-142 RAG cDNA, RIKEN full-length enriched library, clone:G430107K15 product:ribosomal protein S6 kinase, 70kD, polypeptide 2, full insert sequence [AK090093] KLA .97 1.01 .98 .97 .98 1.04 1.07
ATP 1.00 1.08 1.06 1.09 1.11 1.06 1.03
KLA/ATP 1.05 .96 .86 1.03 1.40 1.07 .99
Rps6kb2
KLA  ATP  ATP+KLA
 NM_021485 ribosomal protein S6 kinase, polypeptide 2 (Rps6kb2), mRNA [NM_021485] KLA 1.36 1.40 1.45 1.40 1.63 1.57 1.46
ATP 1.08 1.19 .97 1.15 .90 .99 1.34
KLA/ATP 1.44 1.55 1.09 1.39 1.00 1.12 1.77
Serpine1
KLA  ATP  ATP+KLA
 AK040662 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530009B11 product:serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1, full insert sequence. [AK040662] KLA 1.12 1.08 1.10 1.03 1.00 1.01 1.05
ATP 1.00 1.09 1.39 1.44 1.05 .95 .99
KLA/ATP 1.09 1.10 1.02 1.03 1.08 1.19 1.02
Serpine1
KLA  ATP  ATP+KLA
 NM_008871 serine (or cysteine) peptidase inhibitor, clade E, member 1 (Serpine1), mRNA [NM_008871] KLA 36.00 31.05 27.47 23.20 11.59 4.14 1.47
ATP .97 1.15 3.43 11.58 8.77 7.42 2.16
KLA/ATP 31.47 33.70 38.54 30.90 22.06 23.68 18.57
Slc2a1
KLA  ATP  ATP+KLA
 NM_011400 solute carrier family 2 (facilitated glucose transporter), member 1 (Slc2a1), mRNA [NM_011400] KLA 1.31 1.46 1.10 1.68 1.75 1.95 2.34
ATP .88 .90 1.32 1.99 3.40 10.49 1.93
KLA/ATP 1.13 1.25 1.71 2.14 3.71 6.31 4.63
Stat3
KLA  ATP  ATP+KLA
 NM_213659 signal transducer and activator of transcription 3 (Stat3), transcript variant 1, mRNA [NM_213659] KLA 4.36 4.42 4.67 6.02 4.95 3.45 1.46
ATP 1.01 .97 1.07 1.17 2.47 4.04 1.47
KLA/ATP 4.02 4.57 6.65 6.51 7.06 7.39 3.61
Tceb1
KLA  ATP  ATP+KLA
 NM_026456 transcription elongation factor B (SIII), polypeptide 1 (Tceb1), mRNA [NM_026456] KLA 1.27 1.21 1.25 1.65 1.46 1.21 1.26
ATP 1.11 1.01 1.44 1.34 1.46 1.17 .74
KLA/ATP 1.20 1.48 2.16 1.77 1.56 1.13 .89
Tceb2
KLA  ATP  ATP+KLA
 NM_026305 transcription elongation factor B (SIII), polypeptide 2 (Tceb2), mRNA [NM_026305] KLA .99 1.00 .96 1.01 1.04 .96 1.24
ATP 1.15 1.17 1.03 1.36 1.25 1.05 1.27
KLA/ATP 1.07 1.13 1.08 1.30 1.21 1.23 1.56
Tek
KLA  ATP  ATP+KLA
 AK053336 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130010K24 product:endothelial-specific receptor tyrosine kinase, full insert sequence. [AK053336] KLA .93 .98 .93 .90 .96 1.01 1.10
ATP 1.01 .97 .93 .99 .91 .98 .99
KLA/ATP 1.02 1.06 .95 .93 .92 .91 .92
Tek
KLA  ATP  ATP+KLA
 NM_013690 endothelial-specific receptor tyrosine kinase (Tek), mRNA [NM_013690] KLA 1.00 .95 1.02 .93 .98 .97 1.06
ATP 1.05 1.07 1.01 1.05 .98 1.08 1.13
KLA/ATP .94 .96 1.03 1.11 1.15 .99 1.25
Tfrc
KLA  ATP  ATP+KLA
 NM_011638 transferrin receptor (Tfrc), mRNA [NM_011638] KLA .77 .79 .86 .63 .45 .25 .31
ATP 1.07 1.11 1.09 .89 .75 .45 .17
KLA/ATP .89 .85 .77 .66 .40 .24 .09
Timp1
KLA  ATP  ATP+KLA
 NM_001044384 tissue inhibitor of metalloproteinase 1 (Timp1), transcript variant 1, mRNA [NM_001044384] KLA 4.91 5.11 5.35 6.12 7.31 7.24 4.37
ATP 1.02 1.10 1.31 1.62 2.13 4.52 4.40
KLA/ATP 4.93 5.94 6.45 8.54 6.89 9.58 14.87
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Trf
KLA  ATP  ATP+KLA
 NM_133977 transferrin (Trf), mRNA [NM_133977] KLA .84 .95 .94 .84 .74 .54 .20
ATP 1.02 1.05 .97 1.23 1.04 1.04 .63
KLA/ATP .94 .93 .88 1.07 .71 .77 .40
Vegfa
KLA  ATP  ATP+KLA
 NM_001025250 vascular endothelial growth factor A (Vegfa), transcript variant 1, mRNA [NM_001025250] KLA .49 .48 .46 .46 .39 .64 1.18
ATP 1.05 1.37 3.82 10.55 12.51 24.20 7.85
KLA/ATP .48 .59 1.45 7.42 19.75 27.42 22.35
Vegfa
KLA  ATP  ATP+KLA
 NM_001025257 vascular endothelial growth factor A (Vegfa), transcript variant 3, mRNA [NM_001025257] KLA .72 .71 .66 .70 .65 .80 1.22
ATP 1.01 1.21 3.24 11.12 11.09 18.59 5.43
KLA/ATP .68 .71 1.47 5.94 15.06 20.32 17.31
Vhlh
KLA  ATP  ATP+KLA
 S76748 gb|mVHLh1=von Hippel-Lindau disease gene [mice, mRNA, 2757 nt]. [S76748] KLA 1.39 1.39 1.47 1.46 1.62 1.84 1.48
ATP .73 .64 .54 .55 1.44 2.26 1.44
KLA/ATP 1.17 1.13 .91 .73 1.72 2.26 2.16